Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06098430

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgki…

There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Th…

United States100 participantsStarted 2024-04-04

All recent trials (20 shown)

CompletedPhase 3

NCT00678327

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Sta…

RATIONALE: Imaging procedures, such as fludeoxyglucose F 18 (FDG)-PET/CT scan, done before, during, and after chemotherapy may help doctors assess a patient's r…

United Kingdom1,202 participantsStarted 2008-08-29

Treatment: bleomycin sulfate, filgrastim

CompletedPhase 1

NCT01588015

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Ste…

This randomized phase I trial studies the side effects of vaccine therapy in preventing cytomegalovirus (CMV) infection in patients with hematological malignanc…

United States36 participantsStarted 2012-10-29

Treatment: tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis

Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgki…

All recent trials (20 shown)

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Sta…

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Ste…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgki…

All recent trials (20 shown)

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Sta…

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Ste…

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or H…

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF…

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymph…

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or…

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgki…

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refra…

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to…

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma